JP2016506366A5 - - Google Patents

Download PDF

Info

Publication number
JP2016506366A5
JP2016506366A5 JP2015541857A JP2015541857A JP2016506366A5 JP 2016506366 A5 JP2016506366 A5 JP 2016506366A5 JP 2015541857 A JP2015541857 A JP 2015541857A JP 2015541857 A JP2015541857 A JP 2015541857A JP 2016506366 A5 JP2016506366 A5 JP 2016506366A5
Authority
JP
Japan
Prior art keywords
insulin
wild
prior
patent document
documents cited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015541857A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016506366A (ja
JP6584953B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/068585 external-priority patent/WO2014071405A2/en
Publication of JP2016506366A publication Critical patent/JP2016506366A/ja
Publication of JP2016506366A5 publication Critical patent/JP2016506366A5/ja
Application granted granted Critical
Publication of JP6584953B2 publication Critical patent/JP6584953B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015541857A 2012-11-05 2013-11-05 長時間作用型単鎖インスリン類似体 Expired - Fee Related JP6584953B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261722350P 2012-11-05 2012-11-05
US61/722,350 2012-11-05
PCT/US2013/068585 WO2014071405A2 (en) 2012-11-05 2013-11-05 Long-acting single-chain insulin analogues

Publications (3)

Publication Number Publication Date
JP2016506366A JP2016506366A (ja) 2016-03-03
JP2016506366A5 true JP2016506366A5 (OSRAM) 2016-12-15
JP6584953B2 JP6584953B2 (ja) 2019-10-02

Family

ID=50628271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015541857A Expired - Fee Related JP6584953B2 (ja) 2012-11-05 2013-11-05 長時間作用型単鎖インスリン類似体

Country Status (15)

Country Link
US (2) US9499600B2 (OSRAM)
EP (1) EP2914620B1 (OSRAM)
JP (1) JP6584953B2 (OSRAM)
KR (1) KR102163936B1 (OSRAM)
CN (2) CN105008395B (OSRAM)
AU (1) AU2013337250B2 (OSRAM)
BR (1) BR112015010194B1 (OSRAM)
CA (1) CA2890719C (OSRAM)
EA (1) EA201590882A1 (OSRAM)
ES (1) ES2694418T3 (OSRAM)
IL (1) IL238651B (OSRAM)
MX (1) MX2015005662A (OSRAM)
PH (1) PH12015500989A1 (OSRAM)
SG (1) SG11201503522RA (OSRAM)
WO (1) WO2014071405A2 (OSRAM)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9624287B2 (en) 2012-07-17 2017-04-18 Case Western Reserve University O-linked carbohydrate-modified insulin analogues
WO2014015078A1 (en) * 2012-07-17 2014-01-23 Michael Weiss O-linked carbohydrate-modified insulin analogues
US9901622B2 (en) 2014-01-13 2018-02-27 Thermalin Diabetes, Inc. Rapid action insulin formulations and pharmaceutical delivery systems
CZ308383B6 (cs) * 2014-06-30 2020-07-15 Ústav Organické Chemie A Biochemie Akademie Věd Čr, V.V.I. Derivát inzulinu s cyklickou strukturou v C-konci B-řetězce
KR102569743B1 (ko) 2014-10-06 2023-08-23 케이스 웨스턴 리저브 유니버시티 이상 단일 사슬 인슐린 유사체
AR105616A1 (es) 2015-05-07 2017-10-25 Lilly Co Eli Proteínas de fusión
EP3393498A4 (en) * 2015-12-23 2019-08-07 Case Western Reserve University SECULATION OF ULTRASTABILEN INSULIN ANALOGUE WITH POLYMER MELTS
WO2020106748A1 (en) * 2018-11-19 2020-05-28 Case Western Reserve University Single-chain insulin analogues with poly-alanine c-domain sub-segments
BR112021011050A2 (pt) 2018-12-11 2021-08-31 Sanofi Ligante peptídico
TW202434620A (zh) 2019-07-31 2024-09-01 美商美國禮來大藥廠 鬆弛素(relaxin)類似物及其使用方法
EP4073096A1 (en) * 2019-12-10 2022-10-19 Sanofi A method of forming a conjugate of a sulfonamide and a polypeptide
WO2023041758A1 (en) 2021-09-20 2023-03-23 Kyon Biotech Ag Arginase-insulin fusion protein

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100449454B1 (ko) * 2000-10-02 2004-09-21 이현철 단일사슬 인슐린 유도체의 유전자를 포함하는 당뇨병치료용 벡터
EP1193272B1 (en) * 2000-10-02 2004-06-30 Yonsei University Single-chain insulin analogs
KR20050121748A (ko) * 2003-04-29 2005-12-27 일라이 릴리 앤드 캄파니 연장된 시간 작용을 갖는 인슐린 유사체
KR100508616B1 (ko) * 2003-06-20 2005-08-17 신항철 염기성 아미노산 첨가를 통한 활성이 증가된 단일사슬 인슐린 아날로그
ATE517119T1 (de) * 2003-12-03 2011-08-15 Novo Nordisk As Einzelketteninsulin
ES2554773T3 (es) * 2006-10-04 2015-12-23 Case Western Reserve University Insulina y análogos de la insulina resistentes a la fibrilación
RU2010147076A (ru) * 2008-04-22 2012-05-27 Кейз Вестерн Ризев Юнивесити (Us) Аналоги инсулина специфичные к изоформам
MX2012000304A (es) * 2009-07-06 2012-01-27 Sanofi Aventis Deutschland Preparaciones insulinicas que comprenden metionina.
TW201105346A (en) 2009-07-06 2011-02-16 Sanofi Aventis Deutschland Heat-stable and vibration-stable insulin preparations
US8399407B2 (en) 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
US9908925B2 (en) * 2011-10-27 2018-03-06 Case Western Reserve University Ultra-concentrated rapid-acting insulin analogue formulations
US20150299286A1 (en) * 2012-01-20 2015-10-22 Case Western Reserve University Glutamic acid-stabilized insulin analogues
CN104981251B (zh) * 2012-09-26 2018-03-20 印第安纳大学研究及科技有限公司 胰岛素类似物二聚体

Similar Documents

Publication Publication Date Title
JP2016506366A5 (OSRAM)
CY2022035I1 (el) Βελτιστοποιηση αντισωματων που δεσμευουν το γονιδιο-3 ενεργοποιησης λεμφοκυτταρων (lag-3), και χρησεις εξ' αυτων
HUE060029T2 (hu) Emberi antitestek, amelyek kötnek limfocita aktivációs gént-3 (LAG-3) és azok felhasználásai
JP2017515162A5 (OSRAM)
JP2014533241A5 (OSRAM)
JP2014525291A5 (OSRAM)
HUE037205T2 (hu) Antitestek, amelyek IL-4-et és/vagy IL-13-at kötnek és alkalmazásaik
HUE063272T2 (hu) Zika-vírus epitópokhoz specifikusan kötõdõ új antitestek és alkalmazásaik
JP2014519854A5 (OSRAM)
CL2015000420A1 (es) Anticuerpo de unión a gfr alfa 3 (gfra3); ácido nucleico que lo codifica; vector; método para producirlo; composición farmacéutica que lo comprende; y uso para tratar una afección o enfermedad relacionada con gfra3.
JP2017514877A5 (OSRAM)
MA32980B1 (fr) Proteines de liaison a la myostatine
BRPI0813237A2 (pt) Composto, método para preparar o composto, composição, medicamento, e, uso do composto.
JP2007254881A5 (OSRAM)
GB201101540D0 (en) Analyzing server copies of client files
CL2008001069A1 (es) Compuestos derivados de tetrahidroindazoles y tetrahidroindoles; procedimiento de preparacion; y su uso para tratar una enfermedad o trastorno relacionado con la proliferacion celular.
JP2018520447A5 (OSRAM)
JP2015518494A5 (OSRAM)
JP2014508098A5 (OSRAM)
DK3725803T3 (da) Bindingsmolekyler som binder human komplementfaktor C2b, og anvendelser deraf
JP2013515494A5 (OSRAM)
JP2016527801A5 (OSRAM)
JP2012518044A5 (OSRAM)
JP2011082627A5 (OSRAM)
JP2014162977A5 (OSRAM)